post-inflammatory hyperpigmentation
News
13.07.2016
Cynosure to Ring NASDAQ Stock Market Closing Bell to Celebrate 25 Year Anniversary
Cynosure, Inc. (NASDAQ: CYNO) today announced that President and CEO Michael Davin, along with other members of the Company’s management team, will ring the Closing Bell at the NASDAQ Stock […]
02.12.2015
5th Annual Meeting World Academy of Cosmetic Surgery, June 24 – 25, 2016
We have put together the best photos of the Annual Meeting which you can see further down in our photo gallery. The special issue of Cosmetic Medicine with the […]
21.09.2016
Cynosure Receives Approval to Market SculpSure® in South Korea
“MFDS approval of SculpSure is another major step in our international growth strategy for this breakthrough non-invasive fat-reduction treatment,” said Cynosure President and Chief Executive Officer Michael Davin. “As one […]